We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Quantum Genomics Corp Partners with Inserm in Stroke and Cardiac Ischemia Drug Development

News   Jan 25, 2008

 
Quantum Genomics Corp Partners with Inserm in Stroke and Cardiac Ischemia Drug Development
 
 
 

RELATED ARTICLES

Protein Therapy Boosts Spinal Cord Regeneration in Mice

News

Restoring the ability to walk following spinal cord injury requires neurons in the brain to reestablish communication pathways with neurons in the spinal cord, Mature neurons, however, are unable to regenerate their axons to facilitate this process. New research in mice shows one potential route to overcome this limitation may be by targeting liver kinase B1 (LKB1) protein.

READ MORE

Molecule Could Transform the Treatment of Diabetes

News

Scientists from the University of Bristol have designed a new synthetic glucose binding molecule platform that brings us one step closer to the development of the world's first glucose-responsive insulin which, say researchers, will transform the treatment of diabetes.

READ MORE

Molecule Fights Muscular Paralysis

News

UNIGE researchers have identified a molecule that can halt the progress of a severe genetic disease that causes whole-body muscle paralysis followed by death.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Genomics Research Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE